{"entity":{"type":"insider","cik":"0001258673","url":"/insider/0001258673","json_url":"/insider/0001258673.json","name":"KOVEN ANDREW I","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":10,"first":"2005-05-10","last":"2018-06-06","span_basis":"filed_date"},"name_variants":[{"name":"KOVEN ANDREW I","source":"filing","n_filings":10,"first_seen":"2005-05-10","last_seen":"2018-06-06"}],"transactions":[{"id":6681384,"accession":"0001104659-18-038619","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-038619","line_url":"/filing/0001104659-18-038619#line-1","is_derivative":false,"issuer_cik":"0001258673","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001258673","owner_cik":"0001258673","owner_name":"KOVEN ANDREW I","owner_display_name":"KOVEN ANDREW I","owner_url":"/insider/0001258673","role":"Officer (President & Chief Business Off)","role_mark":"O","role_mark_label":"Officer (President & Chief Business Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Business Off","security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":156573.0,"shares_display":"156,573","price_per_share":0.3742,"price_display":"0.37","price_state":"stated","total_value":58589.6166,"total_display":"58,589.62","total_whole":"58,590","shares_owned_after":1183419.0,"shares_owned_after_display":"1,183,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-04","filed_date":"2018-06-06","scope":"insider"},{"id":6540826,"accession":"0001104659-18-033906","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-033906","line_url":"/filing/0001104659-18-033906#line-1","is_derivative":false,"issuer_cik":"0001258673","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001258673","owner_cik":"0001258673","owner_name":"KOVEN ANDREW I","owner_display_name":"KOVEN ANDREW I","owner_url":"/insider/0001258673","role":"Officer (President & Chief Business Off)","role_mark":"O","role_mark_label":"Officer (President & Chief Business Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Business Off","security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13964.0,"shares_display":"13,964","price_per_share":0.52,"price_display":"0.52","price_state":"stated","total_value":7261.28,"total_display":"7,261.28","total_whole":"7,261","shares_owned_after":1339992.0,"shares_owned_after_display":"1,339,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-14","filed_date":"2018-05-16","scope":"insider"},{"id":5983549,"accession":"0001104659-18-019363","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-019363","line_url":"/filing/0001104659-18-019363#line-1","is_derivative":false,"issuer_cik":"0001258673","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001258673","owner_cik":"0001258673","owner_name":"KOVEN ANDREW I","owner_display_name":"KOVEN ANDREW I","owner_url":"/insider/0001258673","role":"Officer (President & Chief Business Off)","role_mark":"O","role_mark_label":"Officer (President & Chief Business Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Business Off","security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9739.0,"shares_display":"9,739","price_per_share":1.7,"price_display":"1.70","price_state":"stated","total_value":16556.3,"total_display":"16,556.30","total_whole":"16,556","shares_owned_after":1353956.0,"shares_owned_after_display":"1,353,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-19","filed_date":"2018-03-21","scope":"insider"},{"id":4772433,"accession":"0001104659-17-037755","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-037755","line_url":"/filing/0001104659-17-037755#line-1","is_derivative":false,"issuer_cik":"0001258673","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001258673","owner_cik":"0001258673","owner_name":"KOVEN ANDREW I","owner_display_name":"KOVEN ANDREW I","owner_url":"/insider/0001258673","role":"Officer (President & Chief Business Off)","role_mark":"O","role_mark_label":"Officer (President & Chief Business Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Business Off","security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":161906.0,"shares_display":"161,906","price_per_share":1.2792,"price_display":"1.28","price_state":"stated","total_value":207110.1552,"total_display":"207,110.16","total_whole":"207,110","shares_owned_after":1363695.0,"shares_owned_after_display":"1,363,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-05","filed_date":"2017-06-06","scope":"insider"},{"id":4527875,"accession":"0001104659-17-018599","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-018599","line_url":"/filing/0001104659-17-018599#line-1","is_derivative":false,"issuer_cik":"0001258673","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001258673","owner_cik":"0001258673","owner_name":"KOVEN ANDREW I","owner_display_name":"KOVEN ANDREW I","owner_url":"/insider/0001258673","role":"Officer (President & Chief Business Off)","role_mark":"O","role_mark_label":"Officer (President & Chief Business Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Business Off","security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7825.0,"shares_display":"7,825","price_per_share":2.41,"price_display":"2.41","price_state":"stated","total_value":18858.25,"total_display":"18,858.25","total_whole":"18,858","shares_owned_after":1416411.0,"shares_owned_after_display":"1,416,411","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-20","filed_date":"2017-03-22","scope":"insider"},{"id":4302676,"accession":"0001104659-17-017613","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-017613","line_url":"/filing/0001104659-17-017613#line-1","is_derivative":false,"issuer_cik":"0001258673","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001258673","owner_cik":"0001258673","owner_name":"KOVEN ANDREW I","owner_display_name":"KOVEN ANDREW I","owner_url":"/insider/0001258673","role":"Officer (President & Chief Business Off)","role_mark":"O","role_mark_label":"Officer (President & Chief Business Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Business Off","security_title":"Common Shares, without par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.546,"price_display":"2.55","price_state":"stated","total_value":50920.0,"total_display":"50,920.00","total_whole":"50,920","shares_owned_after":1424236.0,"shares_owned_after_display":"1,424,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-15","filed_date":"2017-03-17","scope":"insider"},{"id":3206866,"accession":"0001104659-16-120904","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-120904","line_url":"/filing/0001104659-16-120904#line-1","is_derivative":false,"issuer_cik":"0001258673","issuer_name":"Aralez Pharmaceuticals Inc.","issuer_ticker":"ARLZ","issuer_name_source":null,"issuer_url":"/issuer/0001258673","owner_cik":"0001258673","owner_name":"KOVEN ANDREW I","owner_display_name":"KOVEN ANDREW I","owner_url":"/insider/0001258673","role":"Officer (President & Chief Business Off)","role_mark":"O","role_mark_label":"Officer (President & Chief Business Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & Chief Business Off","security_title":"Common Shares, without par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":71500.0,"shares_display":"71,500","price_per_share":3.4891,"price_display":"3.49","price_state":"stated","total_value":249470.65,"total_display":"249,470.65","total_whole":"249,471","shares_owned_after":1610306.0,"shares_owned_after_display":"1,610,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-12","filed_date":"2016-05-13","scope":"insider"},{"id":6206452,"accession":"0001209191-14-070833","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-070833","line_url":"/filing/0001209191-14-070833","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001258673","owner_name":"KOVEN ANDREW I","owner_display_name":"KOVEN ANDREW I","owner_url":"/insider/0001258673","role":"Officer (EVP, CAO, GC and Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, GC and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, GC and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":139683.0,"shares_display":"139,683","price_per_share":33.43233700378715,"price_display":"33.43","price_state":"stated","total_value":4669929.1297,"total_display":"4,669,929.13","total_whole":"4,669,929","shares_owned_after":38721.0,"shares_owned_after_display":"38,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-21","filed_date":"2014-11-24","scope":"insider","n_lines":2},{"id":1552752,"accession":"0001018952-05-000071","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001018952-05-000071","line_url":"/filing/0001018952-05-000071#line-2","is_derivative":false,"issuer_cik":"0001018952","issuer_name":"KOS PHARMACEUTICALS INC","issuer_ticker":"KOSP","issuer_name_source":null,"issuer_url":"/issuer/0001018952","owner_cik":"0001258673","owner_name":"KOVEN ANDREW I","owner_display_name":"KOVEN ANDREW I","owner_url":"/insider/0001258673","role":"Officer (Exec. VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (Exec. VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, General Counsel","security_title":"Common Stock, $.01 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":70.61,"price_display":"70.61","price_state":"stated","total_value":706100.0,"total_display":"706,100.00","total_whole":"706,100","shares_owned_after":303.0,"shares_owned_after_display":"303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-25","filed_date":"2005-07-26","scope":"insider"},{"id":1595369,"accession":"0001018952-05-000032","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001018952-05-000032","line_url":"/filing/0001018952-05-000032","is_derivative":false,"issuer_cik":"0001018952","issuer_name":"KOS PHARMACEUTICALS INC","issuer_ticker":"KOSP","issuer_name_source":null,"issuer_url":"/issuer/0001018952","owner_cik":"0001258673","owner_name":"KOVEN ANDREW I","owner_display_name":"KOVEN ANDREW I","owner_url":"/insider/0001258673","role":"Officer (Exec.VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (Exec.VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec.VP, General Counsel","security_title":"Common Stock, $.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10625.0,"shares_display":"10,625","price_per_share":53.14,"price_display":"53.14","price_state":"stated","total_value":564612.5,"total_display":"564,612.50","total_whole":"564,613","shares_owned_after":303.0,"shares_owned_after_display":"303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-05-09","filed_date":"2005-05-10","scope":"insider","n_lines":2},{"id":1595365,"accession":"0001018952-05-000032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001018952-05-000032","line_url":"/filing/0001018952-05-000032#line-2","is_derivative":false,"issuer_cik":"0001018952","issuer_name":"KOS PHARMACEUTICALS INC","issuer_ticker":"KOSP","issuer_name_source":null,"issuer_url":"/issuer/0001018952","owner_cik":"0001258673","owner_name":"KOVEN ANDREW I","owner_display_name":"KOVEN ANDREW I","owner_url":"/insider/0001258673","role":"Officer (Exec.VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (Exec.VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec.VP, General Counsel","security_title":"Common Stock, $.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":53.7,"price_display":"53.70","price_state":"stated","total_value":537000.0,"total_display":"537,000.00","total_whole":"537,000","shares_owned_after":303.0,"shares_owned_after_display":"303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-05-06","filed_date":"2005-05-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001660719","name":"Aralez Pharmaceuticals Inc.","url":"/issuer/0001660719","role":"Officer (President & Chief Business Off)","n_filings":7,"first_seen":"2016-05-13","last_seen":"2018-06-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001182129","name":"AUXILIUM PHARMACEUTICALS INC","url":"/issuer/0001182129","role":"Officer (EVP, CAO, GC and Secretary)","n_filings":1,"first_seen":"2014-11-24","last_seen":"2014-11-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001018952","name":"KOS PHARMACEUTICALS INC","url":"/issuer/0001018952","role":"Officer (Exec. VP, General Counsel)","n_filings":2,"first_seen":"2005-05-10","last_seen":"2005-07-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001258673","retrieved_at":"2026-08-25T09:22:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}